Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes-Reference-Cited by-同舟云学术

Development of antibody-modified chitosan nanoparticles for the targeted delivery of siRNA across the blood-brain barrier as a strategy for inhibiting HIV replication in astrocytes

Published:2017-03-17 Issue:4 Volume:7 Page:497-506
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Gu Jijin,Al-Bayati Karam,Ho Emmanuel A.

Funder

Manitoba Health Research Council

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/article/10.1007/s13346-017-0368-5/fulltext.html

Reference42 articles.

1. Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao W, Volsky DJ, et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene. 2002;21:3592–602.

2. Hurwitz AA, Berman JW, Lyman WD. The role of the blood-brain barrier in HIV infection of the central nervous system. Adv Neuroimmunol. 1994;4:249–56.

3. Gray F, Lescs MC, Keohane C, Paraire F, Marc B, Durigon M, et al. Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases. J Neuropathol Exp Neurol. 1992;51:177–85.

4. Skolasky RL, Dal Pan GJ, Olivi A, Lenz FA, Abrams RA, McArthur JC. HIV-associated primary CNS lymorbidity and utility of brain biopsy. J Neurol Sci. 1999;163:32–8.

5. Davies J, Everall IP, Weich S, Glass J, Sharer LR, Cho ES, et al. HIV-associated brain pathology: a comparative international study. Neuropathol Appl Neurobiol. 1998;24:118–24.

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody conjugated targeted nanotherapy epigenetically inhibits calpain-mediated mitochondrial dysfunction to attenuate Parkinson’s disease;Carbohydrate Polymers;2024-12

2. Polymer‐Based Nanoparticles for Inner Ear Targeted Trans Differentiation Gene Therapy;ChemMedChem;2024-07-17

3. Polyglutamine (PolyQ) Diseases: Navigating the Landscape of Neurodegeneration;ACS Chemical Neuroscience;2024-07-12

4. Effect of particle size versus surface charge on the brain targeting behavior of elastic nanovesicles: In-vitro characterization, comparison between I-optimal and D-optimal statistical optimization and in-vivo pharmacokinetic evaluation;Journal of Drug Delivery Science and Technology;2024-06

5. Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands;Journal of Nanobiotechnology;2024-05-17